Skip to main content
Accessibility  |  About  |  Contact  |  Privacy  |  Terms

Histamine May be Possible Drug Target for Multiple Sclerosis

  • Published: 2011-01-31 : Federation of American Societies for Experimental Biology.
  • Synopsis: Histamine could be an important molecule to developing new treatments for multiple sclerosis (MS).

Main Document

More than allergies: Histamine may be a possible drug target for multiple sclerosis - New research published in the Journal of Leukocyte Biology suggests that histamine plays an important role as an immune modulator, which could be a significant finding for multiple sclerosis research.

If you think histamines are your nemesis during allergy season, here's something that might change your perspective. New research published in the Journal of Leukocyte Biology (www.jleukbio.org) shows that histamine could be an important molecule to developing new treatments for multiple sclerosis (MS). In the study, the scientists analyzed the role of histamine in an animal model of multiple sclerosis and found that histamine plays a critical role in preventing MS or lessening its effects.

"We hope that our study will help design new therapies for autoimmune diseases and in particular MS, for which there is still not a definitive cure," said Rosetta Pedotti, MD, Ph.D., a researcher involved in the work from the Neuroimmunology and Neuromuscular Disorders Unit at the Neurological Institute Foundation Carlo Besta in Milan, Italy.

Histamine is a neurotransmitter involved in allergic reactions and other physiological and pathological processes. It is best known for the role it plays in hypersensitivity reactions like allergies, and it generally works by dilating blood vessels and making vessel walls permeable so immune cells can move more easily. Scientists studied the direct effects of histamine and two similar molecules that bind specifically on histamine receptors 1 or 2. Using a mouse model of MS, researchers generated MS-causing T lymphocytes and then treated these cells with histamine or the two other molecules. The effects of these treatments were evaluated by T cell functions analysis including proliferation, cytokine production, intracellular signaling pathways activation, and adhesion to brain vessels. Results showed that histamine reduces the proliferation of myelin autoreactive T lymphocytes and the production of interferon-gamma, a crucial cytokine involved in brain inflammation and demyelination. Additionally, histamine reduced the ability of myelin autoreactive T cells to adhere to inflamed brain vessels, a crucial step in the development of MS.

"This research is very exciting for several reasons. First, it points to unexpected connection between pathways involved in autoimmunity and allergy and suggests previously unrecognized connections between these very different types of immune responses. Second, while extending studies in animal models such as these to humans takes substantially more work, these new data point to a potentially novel drug target for MS and possibly other autoimmune or central nervous system diseases," said John Wherry, Ph.D., Deputy Editor of the Journal of Leukocyte Biology.

The Journal of Leukocyte Biology (www.jleukbio.org) publishes peer-reviewed manuscripts on original investigations focusing on the cellular and molecular biology of leukocytes and on the origins, the developmental biology, biochemistry and functions of granulocytes, lymphocytes, mononuclear phagocytes and other cells involved in host defense and inflammation. The Journal of Leukocyte Biology is published by the Society for Leukocyte Biology.

Details: Marilena Lapilla, Barbara Gallo, Marianna Martinello, Claudio Procaccini, Massimo Costanza, Silvia Musio, Barbara Rossi, Stefano Angiari, Cinthia Farina, Lawrence Steinman, Giuseppe Matarese, Gabriela Constantin, and Rosetta Pedotti. Histamine regulates autoreactive T cell activation and adhesiveness in inflamed brain micro-circulation. J Leukoc Biol February 2011 89:259-267; doi:10.1189/jlb.0910486 ; www.jleukbio.org/content/89/2/259.abstract

Similar Topics

1 - $7M MS Progression Cohort to Research Multiple Sclerosis in Canada - Multiple Sclerosis Society of Canada.
2 - How Can We Predict Whose Multiple Sclerosis Will Worsen? - American Academy of Neurology.
3 - Cladribine Significantly Reduces Brain Atrophy in Patients with Multiple Sclerosis - EMD Inc..
4 - Multiple Sclerosis Onset Age Linked to Geographic Latitude - University of Tasmania.
5 - Stem Cells Show Reversal of Disability in Multiple Sclerosis - Tisch MS Research Center of New York.
From our Multiple Sclerosis section - Full List (48 Items)

Submit disability news, coming events, as well as assistive technology product news and reviews.


Loan Information for low income singles, families, seniors and disabled. Includes home, vehicle and personal loans.


Famous People with Disabilities - Well known people with disabilities and conditions who contributed to society.


List of awareness ribbon colors and their meaning. Also see our calendar of awareness dates.


Blood Pressure Chart - What should your blood pressure be, and information on blood group types/compatibility.



1 - Hearing Charities of America's Hearing Aid Project Changing Lives with Donor's Help
2 - A More Complete Mediterranean Diet May Protect Against Aggressive Prostate Cancer
3 - U.S. Mortality Rate Improvement Slowed by Rise in Obesity
4 - Delta Introduces Enhanced Requirements for Customers Traveling with Service or Support Animals



Citation


Disclaimer: This site does not employ and is not overseen by medical professionals. Content on Disabled World is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. See our Terms of Service for more information.

Reporting Errors: Disabled World is an independent website, your assistance in reporting outdated or inaccurate information is appreciated. If you find an error please let us know.